A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

Clinical trial NCT02403271 · COMPLETED

Trial details

NCT number: NCT02403271
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-Small Cell Lung Cancer Breast Cancer Pancreatic Cancer

Start date: 2015-03-01
Primary completion: 2017-08-01
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.